Hims & Hers Health shares closed at $31.65, down 1.59% from the prior day, underperforming the S&P 500's 0.17% decline. The stock has lost 11.09% over the past month, trailing the Medical sector's 2.54% loss and the S&P 500's 3.52% gain. The company is set to report earnings on August 10, 2026, with analysts expecting an EPS of negative $0.07, a 141.18% drop from the prior-year quarter, on revenue of $690.21 million, up 26.68%. For the full year, the Zacks Consensus Estimates forecast a loss of $0.27 per share and revenue of $2.91 billion, representing changes of negative 150.94% and positive 23.78%, respectively. Hims & Hers Health currently carries a Zacks Rank of 3, or Hold, and trades at a forward P/E of 1206, a significant premium to the industry average of 27.01.
Hims Hers Health IncStock fell 1.59% and underperformed market; upcoming earnings expected to show EPS drop of 141.18%.
